Editas Medicine, Inc. (EDIT)
2.445
-0.30
(-11.09%)
USD |
NASDAQ |
Oct 13, 16:00
2.48
+0.04
(+1.43%)
After-Hours: 20:00
Editas Medicine Total Return Price : 2.445 for Oct. 13, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| October 13, 2026 | 2.445 |
| October 12, 2026 | 2.75 |
| October 09, 2026 | 2.90 |
| October 08, 2026 | 2.84 |
| October 07, 2026 | 2.75 |
| October 06, 2026 | 2.73 |
| October 05, 2026 | 2.79 |
| October 02, 2026 | 2.62 |
| October 01, 2026 | 2.52 |
| September 30, 2026 | 2.57 |
| September 29, 2026 | 2.59 |
| September 28, 2026 | 2.51 |
| September 25, 2026 | 2.58 |
| September 24, 2026 | 2.75 |
| September 23, 2026 | 2.69 |
| September 22, 2026 | 2.92 |
| September 21, 2026 | 2.83 |
| September 18, 2026 | 2.70 |
| September 17, 2026 | 2.72 |
| September 16, 2026 | 2.71 |
| September 15, 2026 | 2.63 |
| September 14, 2026 | 2.74 |
| September 11, 2026 | 2.70 |
| September 10, 2026 | 2.65 |
| September 09, 2026 | 2.77 |
| Date | Value |
|---|---|
| September 08, 2026 | 3.03 |
| September 04, 2026 | 3.23 |
| September 03, 2026 | 3.08 |
| September 02, 2026 | 3.08 |
| September 01, 2026 | 3.07 |
| August 31, 2026 | 3.06 |
| August 28, 2026 | 3.16 |
| August 27, 2026 | 3.30 |
| August 26, 2026 | 3.18 |
| August 25, 2026 | 3.28 |
| August 24, 2026 | 3.00 |
| August 21, 2026 | 3.11 |
| August 20, 2026 | 2.94 |
| August 19, 2026 | 3.25 |
| August 18, 2026 | 2.88 |
| August 17, 2026 | 2.84 |
| August 14, 2026 | 2.82 |
| August 13, 2026 | 2.81 |
| August 12, 2026 | 2.84 |
| August 11, 2026 | 2.95 |
| August 10, 2026 | 2.81 |
| August 07, 2026 | 2.88 |
| August 06, 2026 | 2.90 |
| August 05, 2026 | 2.75 |
| August 04, 2026 | 2.77 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Recursion Pharmaceuticals, Inc. | 3.835 |
| Geron Corp. | 1.20 |
| Halozyme Therapeutics, Inc. | 109.62 |
| Novavax, Inc. | 12.82 |
| AVITA Medical, Inc. | 13.36 |